Retinoblastoma management remains complex, requiring individualized treatment based on
International Classification of Retinoblastoma (ICRB) staging, germline mutation status …

The management of intraocular retinoblastoma is rapidly changing, and even recent reviews
on the subject are behind existing practices. The 4 authors of this report collectively …

Retinoblastoma represents 3% of all childhood cancers, and is the most common intraocular
malignancy of childhood. It is fatal, if untreated. White eye reflex, also known as leukocoria …

Retinoblastoma is a retinal cancer that is initiated in response to biallelic loss of RB1 in
almost all cases, together with other genetic/epigenetic changes culminating in the …

Progress has been made in the past few years in the management of retinoblastoma with
better enucleation implants, chemoreduction-prevention of pinealoblastoma and excellent …

In this report, we explore retinoblastoma diagnostic accuracy and review chemotherapy
alternatives for retinoblastoma using intravenous, intra-arterial, periocular, and intravitreal …

Targeted retinoblastoma management: when to use intravenous,... : Current Opinion in
Ophthalmology Targeted retinoblastoma management: when to use intravenous, intra-arterial …

Retinoblastoma is a rare eye tumor of childhood that arises in the retina. It is the most
common intraocular malignancy of infancy and childhood; with an incidence of 1/15,000 …

This report presents the recommendations of the WHO Expert Committee responsible for
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …

Retinoblastoma is the most common intraocular tumor in children. The diagnosis is usually
established by the ophthalmologist on the basis of fundoscopy and US. Together with US …